Methylene tetrahydrofolate reductase gene mutation together with anticardiolipin antibody during pregnancy

a case report

Authors

  • Egle Couto Universidade Estadual de Campinas
  • Ricardo Barini Universidade Estadual de Campinas
  • Marcelo Luís Nomura Universidade Estadual de Campinas
  • Joyce Maria Annichino-Bizzacchi Universidade Estadual de Campinas
  • João Luiz Pinto e Silva Universidade Estadual de Campinas

Keywords:

Anticardiolipin antibodies, Tetrahydrofolate, Reductase, Thrombosis, Antiphospholipid syndrome

Abstract

CONTEXT: High plasmatic homocysteine levels have been associated with arterial and venous thrombosis. The C677T methylene tetrahydrofolate reductase (MTHFR) gene mutation is one of the known causes for high homocysteine levels in plasma. Anticardiolipin antibody (ACA) is also associated with thrombosis and, along with other clinical complications such as recurrent abortion and stillbirth, is part of the antiphospholipid syndrome. DESIGN: Case report. CASE REPORT: A 19-year-old woman with two gestations and one parity (G2P1) had exhibited deep venous thrombosis in her previous puerperal period. Investigation of thrombophilic factors revealed ACA-IgM and heterozygous C677T mutation in the MTHFR gene. Lupus anticoagulant, protein C, protein S and antithrombin III deficiencies, and Leiden factor V and the G20210A mutation in the prothrombin gene, were not detected. The patient received 55,000 IU of subcutaneous heparin daily, from the 15th to the 36th week of pregnancy, when vaginal delivery took place. There were no clinical complications during the puerperal period and she was discharged three days after delivery, while still using oral anticoagulants.

Downloads

Download data is not yet available.

Author Biographies

Egle Couto, Universidade Estadual de Campinas

MD, PhD. Departamento de Ginecologia e Obstetrícia, Universidade Estadual de Campinas, Campinas, São Paulo, Brazil.

Ricardo Barini, Universidade Estadual de Campinas

MD, PhD. Departamento de Ginecologia e Obstetrícia, Universidade Estadual de Campinas, Campinas, São Paulo, Brazil.

Marcelo Luís Nomura, Universidade Estadual de Campinas

MD. Departamento de Ginecologia e Obstetrícia, Universidade Estadual de Campinas, Campinas, São Paulo, Brazil.

Joyce Maria Annichino-Bizzacchi, Universidade Estadual de Campinas

MD, PhD. Departamento de Clínica Médica, Disciplina de Hematologia, Universidade Estadual de Campinas, Campinas, São Paulo,Brazil.

João Luiz Pinto e Silva, Universidade Estadual de Campinas

MD, PhD. Departamento de Ginecologia e Obstetrícia, Universidade Estadual de Campinas, Campinas, São Paulo, Brazil.

References

Lockshin MD, Druzin ML, Goei S, Qamar T, Magid MS, Jovanovic L, Ferenc M. Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lu- pus erythematosus. N Engl J Med 1985;313:152-6.

Lane DA, Mannucci PM, Bauer KA, et al. Inherited thrombophilia: Part 1. Thromb Haemost 1996;76(5):651-62.

Triplett DA. Use of dilute Russell viper venom time (dRVVT): its importance and pitfalls. J Autoimmun 2000;15(2):173-8.

Asherson RA, Piette JC. The catastrophic antiphospholipid syndrome: acute multi-organ failure associated with antiphospholipid antibodies: a review of 31 patients. Lupus 1996;5(5):414-417.

Kupferminc MJ, Eldor A, Steinman N, Many A, Bar-am A, Jaffa A, Fait G, Lessing JB. Increased frequency of genetic throm- bophilia in women with complications of pregnancy. N Engl J Med 1999;340:9-13.

Downloads

Published

2002-09-09

How to Cite

1.
Couto E, Barini R, Nomura ML, Annichino-Bizzacchi JM, Silva JLP e. Methylene tetrahydrofolate reductase gene mutation together with anticardiolipin antibody during pregnancy: a case report. Sao Paulo Med J [Internet]. 2002 Sep. 9 [cited 2025 Oct. 16];120(5):152-3. Available from: https://periodicosapm.emnuvens.com.br/spmj/article/view/2720

Issue

Section

Case Report